Ionis Pharmaceuticals, Inc.
Compounds and methods for the modulation of proteins

Last updated:

Abstract:

In certain embodiments, the present disclosure provides compounds and methods of increasing the amount or activity of a target protein in a cell. In certain embodiments, the compounds comprise a translation suppression element inhibitor. In certain embodiments, the translation suppression element inhibitor is a uORF inhibitor. In certain embodiments, the uORF inhibitor is an antisense compound.

Status:
Grant
Type:

Utility

Filling date:

16 Nov 2015

Issue date:

3 Nov 2020